Implementation of Sexually Transmitted Infection Chemoprophylaxis in the United States
- PMID: 36729637
- DOI: 10.1097/OLQ.0000000000001754
Implementation of Sexually Transmitted Infection Chemoprophylaxis in the United States
Conflict of interest statement
Conflict of Interest and Sources of Funding: None declared.
Comment on
-
Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.Sex Transm Dis. 2023 Mar 1;50(3):144-149. doi: 10.1097/OLQ.0000000000001731. Epub 2022 Nov 6. Sex Transm Dis. 2023. PMID: 36730780
References
-
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2020. Atlanta, GA: US Department of Health and Human Services; 2022.
-
- Operario D, Lee JH, Kuo C, et al. Racial and ethnic disparities in HIV and STIs in the United States—National Health and Nutrition Examination Survey 1999–2012. AIDS Patient Care STDs 2015; 29:635–638.
-
- Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 Update: a clinical practice guideline Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf . Published 2021. Accessed December 28, 2022.
-
- Arapali T, Grulich AE, Heywood AE, et al. Factors associated with willingness to use daily antibiotics as sexually transmitted infection prophylaxis among HIV preexposure prophylaxis-experienced gay and bisexual men in Australia. Sex Transm Dis 2023; 50:144–149.
-
- Wilson DP, Prestage GP, Gray RT, et al. Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men. Sex Transm Dis 2011; 38:573–579.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical